Empowering Clinical Research

The global CRO services market is expected to grow from $73.38 billion in 2022 to $163.48 billion by 2029, at a CAGR of more than 12 percent. Adoption of advanced technologies for efficient R&D outcomes and the increasing outsourcing trends in the clinical trials industry has been driving the market growth. In this issue, we have focused on this segment. The cover story of this issue features Lambda. With 20 years of reliable service, the company provides a full range of clinical trial solutions to big pharma, innovator, biopharmaceutical and generic industries. Lambda has the distinction of being one of the first entrants in North America through its acquisition of the R&D unit of Biovail Pharmaceuticals in Toronto, Canada. This provided us the footprint and impetus to foray into the United States market through the acquisition of another niche boutique CRO (Novum Pharmaceutical Research Sciences) with facilities in Pittsburgh and Las Vegas. The issue also covers Bioscience Research Foundation which is amongst the largest CROs in the country with over 150,000 sqft of lab space, 300 scientists across ten departments, a dedicated animal science facility, and over 500 instruments capable of meeting all the pre-clinical needs. With globally recognized certifications, it has acquired the ability to cater to clients' needs from any country.

In addition, the issue also acquaints you with the other top companies in this domain. After studying the industry landscape in-depth, we have zeroed in on the top 10 companies that have excelled in this field with their meticulous approach. Having proven their dedication to efficiency in order to meet the customer expectations in an end-to-end manner, these companies have stood out from the crowd.

We look forward to receiving your feedback and suggestions.